$14.65
17.95% today
NYSE, Aug 13, 10:14 pm CET
ISIN
US1638511089
Symbol
CC

Chemours Co. Target price 2025 - Analyst rating & recommendation

Chemours Co. Classifications & Recommendation:

Buy
67%
Hold
28%
Sell
6%

Chemours Co. Price Target

Target Price $15.30
Price $14.65
Potential
Number of Estimates 13
13 Analysts have issued a price target Chemours Co. 2026 . The average Chemours Co. target price is $15.30. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 18 analysts: 12 Analysts recommend Chemours Co. to buy, 5 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Chemours Co. stock has an average upside potential 2026 of . Most analysts recommend the Chemours Co. stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 5.78 6.07
4.07% 4.93%
EBITDA Margin 13.11% 13.94%
267.50% 6.33%
Net Margin 1.49% 3.91%
137.67% 162.88%

13 Analysts have issued a sales forecast Chemours Co. 2025 . The average Chemours Co. sales estimate is

$6.1b
Unlock
. This is
3.22% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$6.3b 7.08%
Unlock
, the lowest is
$5.6b 4.08%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $5.8b 4.07%
2025
$6.1b 4.93%
Unlock
2026
$6.3b 3.94%
Unlock
2027
$6.6b 5.00%
Unlock

12 Analysts have issued an Chemours Co. EBITDA forecast 2025. The average Chemours Co. EBITDA estimate is

$846m
Unlock
. This is
94.44% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$882m 102.76%
Unlock
, the lowest is
$786m 80.68%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $758m 252.56%
2025
$846m 11.58%
Unlock
2026
$1.0b 18.47%
Unlock
2027
$1.1b 8.38%
Unlock

EBITDA Margin

2024 13.11% 267.50%
2025
13.94% 6.33%
Unlock
2026
15.89% 13.99%
Unlock
2027
16.40% 3.21%
Unlock

12 Chemours Co. Analysts have issued a net profit forecast 2025. The average Chemours Co. net profit estimate is

$237m
Unlock
. This is
156.50% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$291m 169.24%
Unlock
, the lowest is
$172m 140.87%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $86.0m 136.13%
2025
$237m 175.93%
Unlock
2026
$372m 56.56%
Unlock
2027
$426m 14.68%
Unlock

Net Margin

2024 1.49% 137.67%
2025
3.91% 162.88%
Unlock
2026
5.89% 50.64%
Unlock
2027
6.43% 9.17%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 0.57 1.59
135.63% 178.95%
P/E 7.84
EV/Sales 0.91

12 Analysts have issued a Chemours Co. forecast for earnings per share. The average Chemours Co. EPS is

$1.59
Unlock
. This is
156.79% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$1.94 169.29%
Unlock
, the lowest is
$1.15 141.07%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $0.57 135.63%
2025
$1.59 178.95%
Unlock
2026
$2.48 55.97%
Unlock
2027
$2.85 14.92%
Unlock

P/E ratio

Current -4.44 118.85%
2025
7.84 276.75%
Unlock
2026
5.00 36.22%
Unlock
2027
4.36 12.80%
Unlock

Based on analysts' sales estimates for 2025, the Chemours Co. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.94 11.32%
2025
0.91 3.61%
Unlock
2026
0.87 3.80%
Unlock
2027
0.83 4.75%
Unlock

P/S ratio

Current 0.32 32.92%
2025
0.31 3.10%
Unlock
2026
0.29 3.82%
Unlock
2027
0.28 4.75%
Unlock

Current Chemours Co. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Mizuho
Locked
Locked
Locked Jul 15 2025
RBC Capital
Locked
Locked
Locked Jul 03 2025
Barclays
Locked
Locked
Locked May 28 2025
Goldman Sachs
Locked
Locked
Locked May 14 2025
Morgan Stanley
Locked
Locked
Locked May 12 2025
RBC Capital
Locked
Locked
Locked May 08 2025
UBS
Locked
Locked
Locked May 07 2025
Analyst Rating Date
Locked
Mizuho:
Locked
Locked
Jul 15 2025
Locked
RBC Capital:
Locked
Locked
Jul 03 2025
Locked
Barclays:
Locked
Locked
May 28 2025
Locked
Goldman Sachs:
Locked
Locked
May 14 2025
Locked
Morgan Stanley:
Locked
Locked
May 12 2025
Locked
RBC Capital:
Locked
Locked
May 08 2025
Locked
UBS:
Locked
Locked
May 07 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today